NO943631L - Substituerte fenylkarbamater og urinstoffer - Google Patents

Substituerte fenylkarbamater og urinstoffer

Info

Publication number
NO943631L
NO943631L NO943631A NO943631A NO943631L NO 943631 L NO943631 L NO 943631L NO 943631 A NO943631 A NO 943631A NO 943631 A NO943631 A NO 943631A NO 943631 L NO943631 L NO 943631L
Authority
NO
Norway
Prior art keywords
alkyl
phenyl
hydrogen
ureas
benzyl
Prior art date
Application number
NO943631A
Other languages
English (en)
Norwegian (no)
Other versions
NO943631D0 (no
Inventor
Alexander William Oxford
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929206989A external-priority patent/GB9206989D0/en
Priority claimed from GB929217827A external-priority patent/GB9217827D0/en
Priority claimed from GB929221718A external-priority patent/GB9221718D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO943631D0 publication Critical patent/NO943631D0/no
Publication of NO943631L publication Critical patent/NO943631L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO943631A 1992-03-31 1994-09-29 Substituerte fenylkarbamater og urinstoffer NO943631L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB929206989A GB9206989D0 (en) 1992-03-31 1992-03-31 Chemical compounds
GB929217827A GB9217827D0 (en) 1992-08-21 1992-08-21 Chemical compounds
GB929221718A GB9221718D0 (en) 1992-10-16 1992-10-16 Chemical compounds
PCT/EP1993/000779 WO1993020071A1 (en) 1992-03-31 1993-03-26 Substituted phenylcarbamates and phenylureas, their preparation and their use as 5-ht antagonists

Publications (2)

Publication Number Publication Date
NO943631D0 NO943631D0 (no) 1994-09-29
NO943631L true NO943631L (no) 1994-11-29

Family

ID=27266122

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943631A NO943631L (no) 1992-03-31 1994-09-29 Substituerte fenylkarbamater og urinstoffer

Country Status (17)

Country Link
EP (2) EP0972773A1 (cs)
JP (1) JP3236298B2 (cs)
AT (1) ATE188697T1 (cs)
AU (1) AU663780B2 (cs)
CA (1) CA2133083A1 (cs)
CZ (1) CZ236894A3 (cs)
DE (1) DE69327583T2 (cs)
DK (1) DK0640081T3 (cs)
ES (1) ES2141763T3 (cs)
FI (1) FI944513A7 (cs)
GR (1) GR3032877T3 (cs)
HU (1) HUT72321A (cs)
NO (1) NO943631L (cs)
NZ (1) NZ251687A (cs)
PT (1) PT640081E (cs)
SK (1) SK116394A3 (cs)
WO (1) WO1993020071A1 (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU685225B2 (en) * 1994-02-10 1998-01-15 Yamanouchi Pharmaceutical Co., Ltd. Novel carbamate derivative and medicinal composition containing the same
FR2750991A1 (fr) * 1996-07-12 1998-01-16 Pf Medicament Nouveaux benzodioxannes et 1-(2h)-benzopyrannes, leur preparation et leur utilisation comme medicament
FR2752732B1 (fr) 1996-08-28 1998-11-20 Pf Medicament Forme galenique a liberation prolongee de milnacipran
US6693202B1 (en) 1999-02-16 2004-02-17 Theravance, Inc. Muscarinic receptor antagonists
UA73543C2 (uk) * 1999-12-07 2005-08-15 Тераванс, Інк. Похідні сечовини, фармацевтична композиція та застосування похідного при приготуванні лікарського засобу для лікування захворювання, яке опосередковується мускариновим рецептором
DE60021282T2 (de) 1999-12-07 2006-05-18 Theravance, Inc., South San Francisco Carbamat-derivate als muscarin-rezeptor antonisten
CA2418904A1 (en) * 2000-08-07 2002-02-14 Laboratoire Glaxosmithkline S.A.S. Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation
AU2001280187A1 (en) * 2000-08-28 2002-03-13 Toray Industries, Inc. Cyclic amine derivatives
FR2821356A1 (fr) * 2001-02-23 2002-08-30 Cerep Nouveaux derives d'arylcarbamates et d'arylurees, preparations et utilisations
FR2843750B1 (fr) * 2002-08-23 2004-10-22 Cerep Composes derives d'arylcarbamates, preparation et utilisations
PE20040950A1 (es) 2003-02-14 2005-01-01 Theravance Inc DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
ES2329586T3 (es) 2003-11-21 2009-11-27 Theravance, Inc. Compuestos que tienen actividad agonista del receptor beta2 adrenergico y antagonista del receptor muscarino.
WO2006023457A1 (en) 2004-08-16 2006-03-02 Theravance, Inc. COMPOUNDS HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY
WO2006023460A2 (en) 2004-08-16 2006-03-02 Theravance, Inc. COMPOUNDS HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY
GB0602778D0 (en) 2006-02-10 2006-03-22 Glaxo Group Ltd Novel compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA76475B (en) * 1975-03-10 1977-08-31 Ciba Geigy Ag Indolyalkylpiperidines
JPH0140026B2 (cs) * 1978-07-03 1989-08-24 Amerikan Hoomu Purodakutsu Corp
AU611976B2 (en) * 1987-12-24 1991-06-27 John Wyeth & Brother Limited Aroyl urea and carbamic acid derivatives of azabicyclo compounds
DK443489D0 (da) * 1989-09-08 1989-09-08 Ferrosan As Substituerede urinstofforbindelser, deres fremstilling og anvendelse
FR2677019B1 (fr) * 1991-05-27 1994-11-25 Pf Medicament Nouvelles piperidines disubstituees-1,4, leur preparation et leur application en therapeutique.
FR2679555B1 (fr) * 1991-07-25 1993-11-19 Fabre Medicament Pierre Nouveaux derives de l'uree, leur preparation et leur application en therapeutique.

Also Published As

Publication number Publication date
CZ236894A3 (en) 1995-09-13
CA2133083A1 (en) 1993-10-14
GR3032877T3 (en) 2000-07-31
JP3236298B2 (ja) 2001-12-10
PT640081E (pt) 2000-05-31
FI944513A0 (fi) 1994-09-29
ATE188697T1 (de) 2000-01-15
NO943631D0 (no) 1994-09-29
NZ251687A (en) 1995-12-21
JPH07505868A (ja) 1995-06-29
ES2141763T3 (es) 2000-04-01
AU3949793A (en) 1993-11-08
FI944513A7 (fi) 1994-11-29
HU9402825D0 (en) 1994-12-28
WO1993020071A1 (en) 1993-10-14
AU663780B2 (en) 1995-10-19
DK0640081T3 (da) 2000-06-19
DE69327583D1 (de) 2000-02-17
HUT72321A (en) 1996-04-29
SK116394A3 (en) 1995-04-12
EP0972773A1 (en) 2000-01-19
DE69327583T2 (de) 2000-05-31
EP0640081B1 (en) 2000-01-12
EP0640081A1 (en) 1995-03-01

Similar Documents

Publication Publication Date Title
NO943631L (no) Substituerte fenylkarbamater og urinstoffer
HU912610D0 (en) Process for producing benzofurane, benzothiophene, indole and indolysine derivatives and pharmaceutical preparatives containing said compounds
NO905201L (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzofuran-derivater.
UA42684C2 (uk) Похідні бензимідазолону та їх фізіологічно прийнятні кислотно-адитивні солі
NO942316L (no) Isatinderivater, fremgangsmåter for deres fremstilling og farmasöytisk preparat omfattende slike derivater
NO955074L (no) 1-substituerte istain- og oksindolderivater som inhibitorer til acetylkolinesterase
RU2004109141A (ru) Замещенные производные индено[ [1,2-с] изохинолина и способы их применения
AR006619A1 (es) Derivados de aminopiridina, composicion farmaceutica que los contien, metodo para elaborar un medicamento, intermediario quimico para la produccionde dichos compuestos y procedimiento para preparar los derivados de aminopiridina
GR3020848T3 (en) 1,8-Naphthyridin-2-one derivatives
NO942304D0 (no) Nye fosfonoravsyrederivater, fremgangsmåte for fremstilling derav, samt legemiddel inneholdende derivatene
HUP9900351A2 (hu) 2-(4-Helyettesített)-benzilamino-2-metil-propánamidszármazékok, előállításuk és a vegyületeket tartalmazó gyógyszerkészítmények
NO900487D0 (no) Fremgangsmaate for fremstilling av tetrahydrobenzimidazolderivater.
PL257486A1 (en) Method of obtaining novel derivatives of arylocyclobutylalkylamine
NO932998L (no) Nye 4,5-dihydro-4-okso-pyrrolo(1,2-a) kinoksaliner og tilsvarende aza-analoger of fremgangsmaate for fremstilling av dem
NO960747L (no) Benzodiazpinderivater
HU9202449D0 (en) Method for producing substituted 2-amino-1,2,3,4-tetrahydro-naphtaline derivatives and 3-chromane ones thereof
DE3889987D1 (de) N-[(2-Oxopyrrolidin-1-yl)acetyl]piperazin-Derivate und Arzneimittel gegen senile Dementia.
ATE125540T1 (de) Imidazochinolon-derivate.
AU679834B2 (en) Nitroxy group-containing benzylamine derivatives and their use for treating cardiovascular diseases, as well as increased intra-ocular pressure
ES2021261A6 (es) Procedimiento de preparacion de nuevos derivados aminopropanoles racemicos u opticamente activos, sus sales de adicion acida y sus derivados amonicos cuaternarios.
NO982549L (no) 5-naftalen-1-yl-1,3-dioksan-derivater, fremstilling og terapeutisk anvendelse derav
MX9301837A (es) Ureas y fenilcarbamatos substituidos, proceso para su preparacion y composicion farmaceutica que los comprende.
ES486921A1 (es) Procedimiento para preparar derivados de 1-fenil-2-aminoeta-nol
MY107215A (en) 3-piperidinylmethylcarboxylate substituted indoles
NO892761L (no) Fremgangsmaate for fremstilling av inhibitorer for 3-keto-hmg-coa-reduktase.